103 related articles for article (PubMed ID: 38714265)
1. CXCL3: A key player in tumor microenvironment and inflammatory diseases.
Bao Y; Tong C; Xiong X
Life Sci; 2024 Jul; 348():122691. PubMed ID: 38714265
[TBL] [Abstract][Full Text] [Related]
2. CXCL3 Signaling in the Tumor Microenvironment.
Reyes N; Figueroa S; Tiwari R; Geliebter J
Adv Exp Med Biol; 2021; 1302():15-24. PubMed ID: 34286438
[TBL] [Abstract][Full Text] [Related]
3. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.
Xin H; Cao Y; Shao ML; Zhang W; Zhang CB; Wang JT; Liang LC; Shao WW; Qi YL; Li Y; Zhang ZY; Yang Z; Sun YH; Zhang PX; Jia LL; Wang WQ
Int Urol Nephrol; 2018 May; 50(5):861-868. PubMed ID: 29524043
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.
Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
[TBL] [Abstract][Full Text] [Related]
5. CXCL3 positively regulates adipogenic differentiation.
Kusuyama J; Komorizono A; Bandow K; Ohnishi T; Matsuguchi T
J Lipid Res; 2016 Oct; 57(10):1806-1820. PubMed ID: 27512010
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration.
Al-Alwan LA; Chang Y; Mogas A; Halayko AJ; Baglole CJ; Martin JG; Rousseau S; Eidelman DH; Hamid Q
J Immunol; 2013 Sep; 191(5):2731-41. PubMed ID: 23904157
[TBL] [Abstract][Full Text] [Related]
7. CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway.
Qi YL; Li Y; Man XX; Sui HY; Zhao XL; Zhang PX; Qu XS; Zhang H; Wang BX; Li J; Qi SF; Jia LL; Luan HY; Zhang CB; Wang WQ
J Cell Physiol; 2020 May; 235(5):4756-4765. PubMed ID: 31667838
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer.
Gui SL; Teng LC; Wang SQ; Liu S; Lin YL; Zhao XL; Liu L; Sui HY; Yang Y; Liang LC; Wang ML; Li XY; Cao Y; Li FY; Wang WQ
Int Urol Nephrol; 2016 May; 48(5):701-9. PubMed ID: 26837773
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma.
Guan J; Weng J; Ren Q; Zhang C; Hu L; Deng W; Lu S; Dong X; Li W; Li Y; Wang W
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34870709
[TBL] [Abstract][Full Text] [Related]
10. A Critical Role for the CXCL3/CXCL5/CXCR2 Neutrophilic Chemotactic Axis in the Regulation of Type 2 Responses in a Model of Rhinoviral-Induced Asthma Exacerbation.
Sokulsky LA; Garcia-Netto K; Nguyen TH; Girkin JLN; Collison A; Mattes J; Kaiko G; Liu C; Bartlett NW; Yang M; Foster PS
J Immunol; 2020 Nov; 205(9):2468-2478. PubMed ID: 32948685
[TBL] [Abstract][Full Text] [Related]
11. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.
Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H
Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism.
Sun X; He X; Zhang Y; Hosaka K; Andersson P; Wu J; Wu J; Jing X; Du Q; Hui X; Ding B; Guo Z; Hong A; Liu X; Wang Y; Ji Q; Beyaert R; Yang Y; Li Q; Cao Y
Gut; 2022 Jan; 71(1):129-147. PubMed ID: 33568427
[TBL] [Abstract][Full Text] [Related]
13. CXCL3 contributes to CD133(+) CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation.
Zhang L; Zhang L; Li H; Ge C; Zhao F; Tian H; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
Sci Rep; 2016 Jun; 6():27426. PubMed ID: 27255419
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury.
Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Nalepa I; Mika J
Front Immunol; 2019; 10():2198. PubMed ID: 31616413
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of CXCL3-inhibited apoptosis and inflammation in lipopolysaccharide-treated BEAS-2B and HPAEC through inactivating MAPKs pathway.
Wang Y; Pan L
Allergol Immunopathol (Madr); 2022; 50(4):10-16. PubMed ID: 35789398
[TBL] [Abstract][Full Text] [Related]
16. CXCL3 overexpression affects the malignant behavior of oral squamous cell carcinoma cells via the MAPK signaling pathway.
Weng J; Ren Q; Li Z; Wang W; Guan J
J Oral Pathol Med; 2021 Oct; 50(9):902-910. PubMed ID: 34392586
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.
Korbecki J; Kojder K; Kapczuk P; Kupnicka P; GawroĊska-Szklarz B; Gutowska I; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467722
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of the clinical and biological significances for chemokine CXCL3 in cholangiocarcinoma.
Ren H; Yang X; Hou W; Meng J; Luo D; Zhang C
Medicine (Baltimore); 2024 Mar; 103(11):e37460. PubMed ID: 38489741
[TBL] [Abstract][Full Text] [Related]
19. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
Sun X; Chen Q; Zhang L; Chen J; Zhang X
Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and biophysical characterization of CXCL3 chemokine.
Gulati K; Gangele K; Agarwal N; Jamsandekar M; Kumar D; Poluri KM
Int J Biol Macromol; 2018 Feb; 107(Pt A):575-584. PubMed ID: 28928065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
